Regen BioPharma
(OTC) RGBP
Regen BioPharma Financials at a Glance
Market Cap
$77,700
Revenue (TTM)
$236.56K
Net Income (TTM)
$1.73M
EPS (TTM)
$-0.03
P/E Ratio
-0.02
Dividend
$0.00
Beta (Volatility)
0.53 (Low)
Dividend
$0.00
Beta (Volatility)
0.53 (Low)
Price
$0.00
Volume
45,959,719
Open
$0.00
Price
$0.00
Volume
45,959,719
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.12
Dividend
$0.00
Beta (Volatility)
0.53 (Low)
Price
$0.00
Volume
45,959,719
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.12
RGBP News
RGBP: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Regen BioPharma
Industry
Biotechnology
Sector
Health CareEmployees
1
CEO
David Raymond Koos, MD, PhD
Website
www.regenbiopharmainc.comHeadquarters
La Mesa, CA 91942, US
RGBP Financials
Key Financial Metrics (TTM)
Gross Margin
100%
Operating Margin
-4%
Net Income Margin
-7%
Return on Equity
0%
Return on Capital
13%
Return on Assets
-7%
Earnings Yield
-50.00%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$77.70K
Shares Outstanding
129.47M
Volume
45.96M
Short Interest
0.00%
Avg. Volume
7.34M
Financials (TTM)
Gross Profit
$236.56K
Operating Income
$338.54K
EBITDA
$338.54K
Operating Cash Flow
$383.59K
Capital Expenditure
$0.00
Free Cash Flow
$383.59K
Cash & ST Invst.
$716.00
Total Debt
$793.70K
Regen BioPharma Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$59.06K
+0.0%
Gross Profit
$59.06K
+0.0%
Gross Margin
100.00%
N/A
Market Cap
$77.70K
N/A
Market Cap/Employee
$77.70K
N/A
Employees
1
N/A
Net Income
$967.85K
-87.9%
EBITDA
$551.62K
-30.4%
Quarterly Fundamentals
Net Cash
$1.21M
-38.3%
Accounts Receivable
$232.30K
+89.9%
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$1.21M
+38.8%
Return on Assets
-7.28%
N/A
Return on Invested Capital
12.61%
N/A
Free Cash Flow
$197.94K
-198.2%
Operating Cash Flow
$197.94K
-198.2%